Fredun Pharmaceuticals Ltd Q1 FY2023-24 PAT declines QoQ to Rs. 2.40 crore

Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 62.0455 crores during the period ended June 30, 2023 as compared to Rs. 79.8036 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 2.4017 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.8915 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 5.24 for the period ended June 30, 2023 as compared to Rs. 8.59 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 62.0455 crs	₹79.8036 crs	-22.25%
Net Profit	₹2.4017 crs	₹3.8915 crs	-38.28%
EPS	₹5.24	₹8.59	-39.00%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 62.0455 crores during the period ended June 30, 2023 as compared to Rs.48.4168 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.2.4017 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.0.9440 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.5.24 for the period ended June 30, 2023 as compared to Rs.2.12 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 62.0455 crs	₹48.4168 crs	28.15%
Net Profit	₹2.4017 crs	₹0.9440 crs	154.42%
EPS	₹5.24	₹2.12	147.17%

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 1181.80 as compared to the previous close of Rs. 1165.75. The total number of shares traded during the day was 13288 in over 839 trades.

The stock hit an intraday high of Rs. 1249.00 and intraday low of 1165.80. The net turnover during the day was Rs. 15956051.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals Q1FY24 ResultUpdate